Hypertension negatively affects the pregnancy outcome in patients with antiphospholipid syndrome
- 25 May 2012
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 21 (7) , 810-812
Abstract
The impact of hypertension in the pregnancies from autoimmune patients is not unequivocally defined. We have prospectively followed 168 pregnancies from 135 patients from four Italian centres to verify the potential impact of hypertension in the antiphospholipid syndrome (APS). The rate of preeclampsia, mean neonatal weight and gestational age at delivery were significantly lower in patients with both APS and hypertension than in patients with hypertension or APS alone. This information may be relevant for counselling and care of these patients.Keywords
This publication has 7 references indexed in Scilit:
- Pregnancy outcomes in patients with systemic autoimmunityAutoimmunity, 2011
- Chronic Hypertension in PregnancyNew England Journal of Medicine, 2011
- Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control studyRheumatology, 2011
- Translational Mini-Review Series on Immunology of Vascular Disease: Mechanisms of vascular inflammation and remodelling in systemic vasculitisClinical and Experimental Immunology, 2009
- Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunityAutoimmunity, 2007
- Plasma and Tissue Expression of the Long Pentraxin 3 During Normal Pregnancy and PreeclampsiaObstetrics & Gynecology, 2006
- Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-?2-glycoprotein I antibodiesArthritis & Rheumatism, 1999